Search research articles
Contact Us
Filters
Showing results (1-10 of 16) with videos related to
Page
of 2
Sort By:
Metron
|
June 7, 2023
Statistical framework for fully register based population counts
Fabrizio Solari, Antonella Bernardini, Nicoletta Cibella
Veterinary Parasitology
|
November 19, 2025
Safety and efficacy assessment of a chewable tablet containing sarolaner, moxidectin, and pyrantel in the treatment of Angiostrongylus vasorum in dogs
Anne Lloyd, Lore Van Mechelen, Carleen Van Overloop, et al.
Veterinary Parasitology
|
November 28, 2017
Season-long control of flea and tick infestations in a population of cats in the Aeolian archipelago using a collar containing 10% imidacloprid and 4.5% flumethrin
Domenico Otranto, Filipe Dantas-Torres, Ettore Napoli, et al.
Parasitology Research
|
July 19, 2017
Evaluation of the Efficacy and Safety of an Imidacloprid 10 % / Moxidectin 1 % Spot-on Formulation (Advocate<sup>®</sup>, Advantage<sup>®</sup> Multi) in Cats Naturally Infected with Capillaria aerophila
Angela Di Cesare, Fabrizia Veronesi, Gioia Capelli, et al.
Parasites & Vectors
|
January 13, 2019
Effectiveness of the spot-on combination of moxidectin and imidacloprid (Advocate®) in the treatment of ocular thelaziosis by Thelazia callipaeda in naturally infected cats
Domenico Otranto, Fabrizio Solari Basano, Marco Pombi, et al.
Clinical Endocrinology
|
December 20, 2007
Analysis of clinical, ultrasound and colour flow-Doppler characteristics in predicting malignancy in follicular thyroid neoplasms
Pierpaolo Trimboli, Salvatore Ulisse, Michele D'Alò, et al.
Parasites & Vectors
|
May 1, 2012
Therapeutic efficacy of milbemycin oxime/praziquantel oral formulation (Milbemax®) against Thelazia callipaeda in naturally infested dogs and cats
Bruna Motta, Manuela Schnyder, Fabrizio Solari Basano, et al.
The Veterinary Record
|
May 24, 2023
Subcutaneous mast cell tumours: A prospective multi-institutional clinicopathological and prognostic study of 43 dogs
Laura Marconato, Damiano Stefanello, Fabrizio Solari Basano, et al.
Veterinary Parasitology
|
August 16, 2016
Efficacy of moxidectin 2.5% and imidacloprid 10% in the treatment of ocular thelaziosis by Thelazia callipaeda in naturally infected dogs
Domenico Otranto, Vito Colella, Giuseppe Crescenzo, et al.
Parasites & Vectors
|
October 16, 2022
Efficacy of a formulation of sarolaner/moxidectin/pyrantel (Simparica Trio<sup>®</sup>) for the prevention of Thelazia callipaeda canine eyeworm infection
Marcos Antonio Bezerra-Santos, Jairo Alfonso Mendoza-Roldan, Giovanni Sgroi, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 16) with videos related to
Sort By:
Page
of 2
Metron
|
June 7, 2023
Statistical framework for fully register based population counts
Fabrizio Solari, Antonella Bernardini, Nicoletta Cibella
Veterinary Parasitology
|
November 19, 2025
Safety and efficacy assessment of a chewable tablet containing sarolaner, moxidectin, and pyrantel in the treatment of Angiostrongylus vasorum in dogs
Anne Lloyd, Lore Van Mechelen, Carleen Van Overloop, et al.
Veterinary Parasitology
|
November 28, 2017
Season-long control of flea and tick infestations in a population of cats in the Aeolian archipelago using a collar containing 10% imidacloprid and 4.5% flumethrin
Domenico Otranto, Filipe Dantas-Torres, Ettore Napoli, et al.
Parasitology Research
|
July 19, 2017
Evaluation of the Efficacy and Safety of an Imidacloprid 10 % / Moxidectin 1 % Spot-on Formulation (Advocate<sup>®</sup>, Advantage<sup>®</sup> Multi) in Cats Naturally Infected with Capillaria aerophila
Angela Di Cesare, Fabrizia Veronesi, Gioia Capelli, et al.
Parasites & Vectors
|
January 13, 2019
Effectiveness of the spot-on combination of moxidectin and imidacloprid (Advocate®) in the treatment of ocular thelaziosis by Thelazia callipaeda in naturally infected cats
Domenico Otranto, Fabrizio Solari Basano, Marco Pombi, et al.
Clinical Endocrinology
|
December 20, 2007
Analysis of clinical, ultrasound and colour flow-Doppler characteristics in predicting malignancy in follicular thyroid neoplasms
Pierpaolo Trimboli, Salvatore Ulisse, Michele D'Alò, et al.
Parasites & Vectors
|
May 1, 2012
Therapeutic efficacy of milbemycin oxime/praziquantel oral formulation (Milbemax®) against Thelazia callipaeda in naturally infested dogs and cats
Bruna Motta, Manuela Schnyder, Fabrizio Solari Basano, et al.
The Veterinary Record
|
May 24, 2023
Subcutaneous mast cell tumours: A prospective multi-institutional clinicopathological and prognostic study of 43 dogs
Laura Marconato, Damiano Stefanello, Fabrizio Solari Basano, et al.
Veterinary Parasitology
|
August 16, 2016
Efficacy of moxidectin 2.5% and imidacloprid 10% in the treatment of ocular thelaziosis by Thelazia callipaeda in naturally infected dogs
Domenico Otranto, Vito Colella, Giuseppe Crescenzo, et al.
Parasites & Vectors
|
October 16, 2022
Efficacy of a formulation of sarolaner/moxidectin/pyrantel (Simparica Trio<sup>®</sup>) for the prevention of Thelazia callipaeda canine eyeworm infection
Marcos Antonio Bezerra-Santos, Jairo Alfonso Mendoza-Roldan, Giovanni Sgroi, et al.
Page
of 2